Quarterly report pursuant to Section 13 or 15(d)

Profit/(loss) per share - Antidilutive shares (Details)

v3.24.3
Profit/(loss) per share - Antidilutive shares (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Antidilutive securities        
Potentially dilutive equity instruments excluded from the diluted loss per share (in shares) 132,452,050 200,370,627 259,677,864 200,370,627